Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its majority-owned subsidiary, Cyprium Therapeutics, Inc. (“Cyprium”), ...

Porvair is back in focus after analysts lifted their price target by £2.50, supported by a refreshed valuation model that keeps fair value at £9.26. That move reflects updated assumptions that ...

Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 March 27, 2026 8:30 ...

Longeveron Inc. () has held its Q4 earnings call. Read on for the main highlights of the call. Claim 70% Off TipRanks Premium. Unlock hedge fund-level data and powerful investing ...

Rocket Pharmaceuticals (NASDAQ:RCKT) announced that the US Food and Drug Administration (FDA) has granted accelerated ...

I am excited and honored to join Longeveron at this pivotal moment for the company. The strength of the company's stem cell ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today ...

Longeveron Inc. (NASDAQ:LGVN) Q4 2025 Earnings Call Transcript March 17, 2026 Longeveron Inc. beats earnings expectations.

Year of Clinical Validation and Strategic Expansion Across Pipeline, AI Platform Advances Towards Commercialization, and ...

eThekwini Municipality claims stable water supply across most regions, but faces rising demand and challenges from urbanisation and climate conditions ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel ...

Security Tightened Around Noida Airport 5 Police Outposts Set Up Ahead Of CM Yogi's Visit. Greater Noida, March 21 (IANS) As ...